Michael Klichinsky serves as Executive at Carisma Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Michael Klichinsky has executed 6 insider transactions totaling $138.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 7, 2025 involved exercising options for 56,982 shares valued at $6.3K.
Michael Klichinsky currently holds 56,982 shares of Carisma Therapeutics Inc. (CARM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Klichinsky has been a net seller of CARM stock. They have purchased $0 and sold $138.2K worth of shares.
Michael Klichinsky's most recent insider trade was on Oct 7, 2025, when they sold 56,982 shares at $0.11 per share.
Get notified when new Form 4 filings are submitted
| $0.25 |
| Discretionary |
| Oct 3, 2025 | CARM | $31.0K | Sale | 119,347 | $0.26 | Discretionary |
| Oct 2, 2025 | CARM | $50.0K | Sale | 200,000 | $0.25 | Discretionary |
| Oct 1, 2025 | CARM | $42.9K | Sale | 165,000 | $0.26 | Discretionary |
| Mar 7, 2023 | CARM | $0 | Award | 484,347 | $N/A | Discretionary |